Apr 12, 2022 06:05AM Needham & Company Reiterates Buy Rating, $57 Price Target on Harmony Biosciences Holdings Inc. (HRMY)

Apr 4, 2022 08:05AM HARMONY BIOSCIENCES TO PARTICIPATE IN 21st ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE

Mar 9, 2022 08:05AM HARMONY BIOSCIENCES TO PARTICIPATE IN TWO INVESTOR CONFERENCES IN MARCH

Feb 28, 2022 08:17AM Needham & Company Reiterates Harmony Biosciences (HRMY) at Buy, Doesn't Expect Stock to Move on Earnings

Jan 13, 2022 02:23PM Harmony Biosciences' (HRMY) Wakix Continues to Grow, More Upside Possible Should Pandemic Lift - Needham & Company

Dec 2, 2021 07:12AM Harmony’s (HRMY) Phase 3 for pitolisant in IH is Positive Development, Opens Door for Label Expansion - Analyst

Nov 23, 2021 07:08AM Harmony Biosciences Holdings Inc. (HRMY) NDR Highlight Market Opportunity and Cash Flow Capability - Needham & Company

Sep 22, 2021 04:08PM Needham & Company Starts Harmony Biosciences Holdings Inc. (HRMY) at Buy